Oncopeptides AB

ONCO NPV
Create an alert
Sell1.58 SEK
Buy1.59 SEK
0.02 SEK (1.06%)
Last updated today at 12:44 UTC
Trade

Key metrics

Open1.59 SEK
Previous close1.60 SEK
Market capSEK 610.60m
P/E ratio-
Volume576,642
Dividend yield0.00%
EMS-

Company information

Oncopeptides AB is a Sweden-based biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The Company’s lead product candidate PEPAXTO (melphalan flufenamide, also ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue381.15m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 135.40m
Total liabilitiesSEK 194.29m
Net debtSEK 57.13m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.